Recently, accompanied by colleagues from the engineering department, as well as supervisors and construction units, Chairman Wang Xiaoya of Maxin Company conducted an in-depth inspection and guidance at the Maxin Biological Diagnostic Reagent Production Base under construction.
Chairman Wang Xiaoya during the inspection
Chairman Wang Xiaoya firstgained a detailed understanding of the progress of various facility constructions at the base and expressed gratitude to all staff involved in the project for their efficient work. Chairman Wangstated: “The construction of the new base is a crucial process for Maxin to establish itself in theIn vitro diagnosticsindustry, striving to build an international high-standard product R&D and production base. We require every construction personnel to work scientifically, maintain a high sense of responsibility and urgency at all times, and strengthen measures in quality, safety, and supervision,Fully ensuring project progress,ensuring the project is completed with high quality and efficiency by 2023.”
Project construction site
About the Maxin Biological Diagnostic Reagent Production Base
The project will rely on the scientific research and innovation resources of the Southeast China (Fujian) Science City and Fuzhou High-tech Zone, fully leveraging the integrated technological innovation advantages of industry-university-research collaboration between enterprises and universities. It aims to develop a full range of upstream products such as pathology diagnostic antibody reagents and automated instruments with independent intellectual property rights, deepening Maxin’s development towards high-tech content, high added value, and high growth potential, committed to improving national healthcare levels and promoting the company’s economic and social benefits to a new level.
Project commencement site
2021 is the first year of the “14th Five-Year Plan,”Standing at the forefront of the era, opportunities and challenges coexist. MaxinWith unwavering original aspirations,will take the construction of this new base as an opportunity to continuerooting and wholeheartedly serving pathology, contributing its efforts to the realization of the Healthy China strategy andcontributing its strength to the development of human life sciences.
